Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in Netherton Syndrome
NCT02113904Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jan 2014
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of adalimumab in Netherton syndrome (NS), sponsored by Assistance publique - Hôpitaux de Paris. Started Jan 2014; status: completed.
02
Drugs
03
Conditions
Netherton syndrome (NS)
Beyond the preview
Go deeper on NCT02113904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02113904.